Interestingly, compared to the observations obtained from AML cell models, a form of synergistic reduction in CDK6 expression under combination treatment was evident in Patients #3, #4, and #5, respectively (Figure S2). This evidence concerns the gene CDK6 and acute myeloid leukemia.